VR Logo

Cumberland Pharmaceuticals Inc. (CPIX) download report


Healthcare | Drugs & Pharma

Cumberland Pharmaceuticals Inc. (CPIX) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally.

IPO Date: 11-Aug-2009

Founder, Chairman, Pres & CEO: Mr. A. J. Kazimi MBA

Sr. Director of Fin. & Accounting and CFO: Mr. John Michael Hamm

Listing: NASDAQ: CPIX

Country: United States

Headquarters: Nashville, TN

Website: https://www.cumberlandpharma.com

Key Facts

Market cap: $30.12 Mln

Revenue (TTM): $36.62 Mln

Earnings (TTM): $-5.06 Mln

Cash: $17.27 Mln

Total Debt: $20.79 Mln

Insider's Holding: 44.41%

Liquidity: Low

52 Week range: $1.89 - 7.51

Shares outstanding: 14,766,500

10 Years Aggregate:

  • CFO: $36.40 Mln
  • EBITDA: $13.74 Mln
  • Net Profit: $-19.47 Mln

Stock Performance

Time Period Cumberland Pharmaceuticals (CPIX) S&P BSE Healthcare S&P Small-Cap 600
YTD-55.89-17.55-19.23
1 month-1.90-3.85-9.35
3 months-24.82-11.97-16.59
1 Year-29.21-15.43-17.36
3 Years-31.3618.795.90
5 Years-21.549.095.77
10 Years-10.8012.129.78
As on 30-Jun-2022
Year Cumberland Pharmaceuticals (CPIX) S&P Small-Cap 600 S&P BSE Healthcare
202158.3125.2720.87
2020-42.729.5761.45
2019-14.5920.86-3.55
2018-17.98-9.70-5.89
201733.8211.730.49
20164.5624.74-12.88
2015-12.04-3.3615.06